Regulation

Clearing exemption too close to call

Exempting commercial hedgers from mandatory clearing could create a loophole for the institutional investors often blamed for driving up commodity prices, according to the chief lawyer for the Commodity Futures Trading Commission (CFTC), reports Risk.net.

Europe excluded from CCP talks

The exclusion of European Union institutions from a technical working group set up to review risk management standards for central counterparties (CCPs) could make it difficult for the EU to reflect those standards in its forthcoming legislation on over…

A response to Obama's reform plan

Details are being eagerly awaited for US President Barack Obama's banking reform plans announced last week – chiefly, what they mean for the new prop desks that have set up, and for prime brokerage relationships.

Banks banned from prop trading under Obama plan

Financial institutions that own a deposit-taking bank could be forbidden from conducting proprietary trading for their own profit and prohibited from owning, sponsoring or even investing in hedge funds and private equity funds, under new reforms…

The many faces of regulatory arbitrage

Happy new year (belated)! As we enter the new year the regulatory environment remains a key issue driving development, most recently in the form of the CFTC attempting to assert its authority on the US off-exchange retail forex market.

End users get initial support in derivatives ruling

WASHINGTON, DC – The US House of Representatives voted last Thursday (December 10) on amendments detailing significant changes to proposed over-the-counter derivatives legislation, which could favour corporate end users of derivatives.

An imbalanced proposition

At the time of going to press, decisions on the future of the foreign exchange markets was still hanging in the balance, as regulators in the US debated the inclusion of forex swaps and forwards into the over-the-counter derivatives reforms.

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: